Eli Lilly Loses Bid To Limit Ex-FDA Chief's Take In GLP-1 MDL
A Pennsylvania federal judge said Eli Lilly & Co. and plaintiffs in multidistrict litigation accusing it of downplaying side effects of weight loss drugs were talking past each other in a...To view the full article, register now.
Already a subscriber? Click here to view full article